Calciphylaxis

19 registered clinical trials studyying Calciphylaxis — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Calciphylaxis in Patients With Chronic Kidney Disease - A Study of the Danish Calciphylaxis Research Initiativ NCT07511283	Odense University Hospital	—
Not Yet Recruiting	Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications NCT07240649	Jay C. Buckey Jr.	Phase 4
Completed	The SEAPORT 1 Study: Evaluation of the Safety and Tolerability of INZ-701 in Adults With End-Stage Kidney Dise NCT06283589	Inozyme Pharma	Phase 1
Recruiting	Better Evidence and Translation for Calciphylaxis NCT05018221	University of Sydney	Phase 3
Completed	Phase 3 Study of SNF472 for Calciphylaxis NCT04195906	Sanifit Therapeutics S. A.	Phase 3
Recruiting	Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis NCT04592640	The First Affiliated Hospital with Nanjing Medical University	EARLY_Phase 1
Terminated	Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate NCT03319914	Hope Pharmaceuticals	—
Terminated	A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients NCT03150420	Hope Pharmaceuticals	Phase 3
Unknown	The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With C NCT03146793	Centre Hospitalier St Esprit	—
Recruiting	Partners Calciphylaxis Biobank NCT03032835	Massachusetts General Hospital	—
Completed	Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome NCT02854046	Nantes University Hospital	—
Completed	Phase 2 Study With SNF472 in Calciphylaxis Patients NCT02790073	Sanifit Therapeutics S. A.	Phase 2
Unknown	European Calciphylaxis Registry Network NCT02635373	RWTH Aachen University	—
Completed	Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy NCT02278692	Massachusetts General Hospital	N/A
Withdrawn	Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopa NCT02527213	American Regent, Inc.	Phase 3
Completed	Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU) NCT01578382	University of Zurich	—
Completed	Efficacy of Lanthanum Carbonate in Calciphylaxis NCT01289626	University of Wisconsin, Madison	Phase 1
Recruiting	National Registry of Rare Kidney Diseases NCT06065852	UK Kidney Association	—
Recruiting	A Real-World Registry of Chronic Wounds and Ulcers NCT02280733	U.S. Wound Registry	—